#63: The Psychedelic Renaissance - Rick Doblin, PhD
The FitMind Podcast: Mental Fitness, Neuroscience & Psychology
00:00
The FDA's REMS Program for Psilocybin
For psilocybin, for MDMA, the drug is not the therapy. It's the psychotherapy. And I think the FDA doesn't regulate psychotherapy. They don't understand psychotherapy. We're having some problems with the FDA because they've indicated that in our phase three studies and our phase two studies, we have a two-person therapy team,. The lead person is a licensed therapist. The second person is a student even learning to get a license.
Transcript
Play full episode
